Innovation Pharmaceuticals Inc (IPIX)

[Loose Lips]

Wrong on all accounts:
1) Trial progression is the literal demonstration of a drug being successful. If a trail fails, the drug no longer advances and does not get to market. Successful phase 1 trials lead to phase 2 trails. Successful phase 2 trials show the drug is working which leads to the phase 3 trial to dial it in for the maximum results. Successful phase 3 typically leads to market approval.
2) Good management keeps focused on the steps necessary to secure funding and execute trials while navigating the complex FDA regulations to pave the way for advancement and approval.
3) The pipeline equates to advancing share price because the larger and more diverse it is, the greater chance one of the drugs will succeed and bring in revenue and increase the value of the company.
4) Potential equates to both successful trials and advancing share price. CTIX purposefully performs the pre-clinical trials in models that have been used by drugs with proven efficacy to minimize the risk of failure and provide the best possible indication of how well a drug will work in humans (i.e. Purisol). The indication of the drugs potential directly equates to the chances of success trials and success in trials leads to advancing share price. Potential is what most biotech investors are investing in when they buy a company's stock. If there is not any potential for success then there is no reason to invest.

Mr. Market (institutional investors, not retail) is just waiting for the illegal shenanigans and false information that have occurred with CTIX to be cleared up before they can follow their internal investing rules and buy into the winning company called Cellceutix.